'Acceptable endpoint' presentation slideshows

Jaro Vostal, MD, PhD Division of Hematology, OBRR,CBER, FDA Blood Products Advisory Committee

PRODUCT DEVELOPMENT PROGRAM FOR INTERVENTIONS IN SEVERE BLEEDING DUE TO TRAUMA OR OTHER CAUSES co-sponsored by: DOD, FDA, HHS Office of the Assistant Secretary for Health and NHLBI. Jaro Vostal, MD, PhD Division of Hematology, OBRR,CBER, FDA Blood Products Advisory Committee

560 views • 14 slides